These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20214303)

  • 41. Reversal of cirrhosis: evidence-based medicine?
    Desmet VJ; Roskams T
    Gastroenterology; 2003 Aug; 125(2):629-30; author reply 630-31. PubMed ID: 12891578
    [No Abstract]   [Full Text] [Related]  

  • 42. Peginterferon and ribavirin for hepatitis C.
    Leiner S
    N Engl J Med; 2007 Mar; 356(12):1270; author reply 1271. PubMed ID: 17380577
    [No Abstract]   [Full Text] [Related]  

  • 43. [Two-step interferon rebound therapy].
    Kato M; Yuki N; Iyoda K; Yamamoto K; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):497-501. PubMed ID: 15359849
    [No Abstract]   [Full Text] [Related]  

  • 44. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of chronic hepatitis C with pegylated alpha-interferons].
    Niederau C
    Dtsch Med Wochenschr; 2002 Mar; 127(11):563-6. PubMed ID: 11894177
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment for chronic hepatitis C, more opportunity, more challenge].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676
    [No Abstract]   [Full Text] [Related]  

  • 47. [Retreatment strategies for the patients with HCV infection].
    Pawłowska M
    Przegl Epidemiol; 2005; 59(2):591-4. PubMed ID: 16190570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels.
    Puoti C; Bellis L; Castellacci R; Montagnese F
    Hepatology; 2005 Mar; 41(3):683; author reply 684. PubMed ID: 15723301
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapy of chronic hepatitis C].
    Moradpour D; Blum HE
    Praxis (Bern 1994); 2006 Sep; 95(38):1451-7. PubMed ID: 17058595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response].
    Zeuzem S
    MMW Fortschr Med; 2002 Feb; 144(8):30-4. PubMed ID: 11910820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hepatitis C. Chances for treatment increase].
    MMW Fortschr Med; 2001 Mar; 143(10):47. PubMed ID: 11268741
    [No Abstract]   [Full Text] [Related]  

  • 52. Comment to "Treating chronic hepatitis C in recovering opiate addicts: yes, we can".
    Guadagnino V
    Dig Liver Dis; 2010 Apr; 42(4):305; author reply 305-6. PubMed ID: 19709937
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: further evidence in decompensation cirrhosis.
    Ji F; Zhang S; Deng H; Li Z
    J Hepatol; 2013 Jun; 58(6):1262-4. PubMed ID: 23395693
    [No Abstract]   [Full Text] [Related]  

  • 54. Education by a nurse increases the adherence to therapy in chronic hepatitis C patients.
    Alavian SM; Aalaei-Andabili SH
    Clin Gastroenterol Hepatol; 2012 Feb; 10(2):203; author reply 203. PubMed ID: 21839708
    [No Abstract]   [Full Text] [Related]  

  • 55. Changing faces-natural course and treatment of hepatitis C after liver transplantation.
    Bahr MJ; Manns MP
    J Hepatol; 2004 Apr; 40(4):699-701. PubMed ID: 15030989
    [No Abstract]   [Full Text] [Related]  

  • 56. [Groundbreaking new data for HIV and hepatitis B and C. What will change in 2010?].
    Jablonowski H; Mauss S
    MMW Fortschr Med; 2010 Apr; 152(17):26. PubMed ID: 20509255
    [No Abstract]   [Full Text] [Related]  

  • 57. Antiviral treatment of HCV-related chronic hepatitis: is the cup half empty, or half full?
    Puoti C
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):171-2. PubMed ID: 17592565
    [No Abstract]   [Full Text] [Related]  

  • 58. Introduction. Necroinflammation and the course of chronic hepatitis.
    Craxì A
    Dig Liver Dis; 2007 Nov; 39 Suppl 3():S369-71. PubMed ID: 18063257
    [No Abstract]   [Full Text] [Related]  

  • 59. Antifibrogenic activity of interferon alpha in chronic hepatitis C.
    Suou T
    J Gastroenterol; 1999 Jun; 34(3):426-7. PubMed ID: 10433027
    [No Abstract]   [Full Text] [Related]  

  • 60. [Moderate and prolonged increase of transaminases serum activity. Management].
    Capron JP
    Presse Med; 1989 May; 18(18):913-6. PubMed ID: 2524778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.